Experimental Hematology · 2009 · 15 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular PharmacologyHematologic Malignancy PharmacotherapyOncology PharmacologyPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsAcute Leukemia ChemotherapyAcute Myeloid Leukemia BiologyAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentAdditive ResponseTherapeutic Tyrosine Kinase InhibitorsVegfr InhibitorsVegfr-3 Signaling
36
Christian Thiede, Christine Steudel, Brigitte Mohr et al. · Blood · 2002 · 1.7K citations · Full text
Medicine, Genetics, Hematology +14
Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew et al. · Blood · 2001 · 1.5K citations · Full text
Life Sciences, Genetics, Hematology +16
Bob Löwenberg, James R. Downing, Alan K. Burnett · New England Journal of Medicine · 1999 · 1.2K citations
Susanne Schnittger, Claudia Schoch, Martin Dugas et al. · Blood · 2002 · 964 citations · Full text
Medicine, Hematology, Oncology +17
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 857 citations · Full text
Medicine, Oncology, Pharmacology +11